Your enthusiasm reminds me of how I felt near the beginning of April with up-listing "imminent" and several pieces of good news (and the possible addition to the Russell index) coming. I'm not a trader but I was so enthusiastic that I bought some "trading shares" at a little over $3. I foolishly did this even though I was already overweighted with CTIX. (I know. Buying those shares was my mistake and entirely my fault.)
Now I'm still holding those CTIX "traders" while I watch the stock I was originally planning to put that money in rise by 30%. But c'est la vie.
However, this time I'm going curb my enthusiasm until I see whether Super CEO or Clark Kent comes out of that phone booth.
FDA meeting countdown starts now: I'm going to assume it takes place on Wednesday the 24th. Which means 9 trading days to go.
To me, this is the one pivotal event I've been anticipating most this year. Their likely approval of Phase III trial for ABSSSI based on review of highly detailed P2B data will provide validation of the whole defensin mimetic platform. Additionally, will open the door for fast track and priority review. Also, as alluded to by LEO, is a major milestone needed before he is looking to advance into serious partnership talks. Start of P3 will bring $$$ monetization of one of our products closer than ever, more realistic than ever, more probable than ever, and therefore more priced in than ever.
All this should only boost share price, bring us to Nasdaq, bring in institutional investors, and further carry CTIX higher. Positive snowball. Can't wait. - ericseb2003